In the present study, although typhaneoside treatment did not significantly improve DSS colitis in mice, we found typhaneoside can prevent DVF-mediated activation of LRRC19 signaling and exacerbation of colonic inflammation. The gene discussed is LRRC19; the disease is colitis.